FDA to Build $600 Million Campus

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 2
Volume 4
Issue 2

ROCKVILLE, Md--By the year 2003, the FDA hopes to be settled into its new 539-acre home in Clarksburg, Md, a small farming community about 15 miles north of the agency's main Rockville headquarters.

ROCKVILLE, Md--By the year 2003, the FDA hopes to be settled intoits new 539-acre home in Clarksburg, Md, a small farming communityabout 15 miles north of the agency's main Rockville headquarters.

The project should receive final approval in June after completionof an environmental impact study, and construction is scheduledto begin next year. More than 6,000 FDA workers, now scatteredamong dozens of sites, will move to the Clarksburg campus. Accesswill be from an existing interstate highway, but the new sitewill not be near public transportation.

Recent Videos
Co-hosts Kristie L. Kahl and Andrew Svonavec highlight what to look forward to at the 2025 ESMO Annual Congress, from hot topics and emerging trends to travel recommendations.
Andrezj Jakubowiak, MD, PhD, prioritizes KRd-based regimens for the treatment of high-risk newly diagnosed disease in the post-transplant setting.
2 KOLs are featured in this series.
A new clinical trial aims to offer a novel allogenic CAR T-cell product for patients with lymphoma closer to home.
Although a similar proportion achieved MRD negativity at the 10 to the –6 power, not enough studies have analyzed MRD at this level for multiple myeloma.
Determining the molecular characteristics of one’s disease may influence the therapy employed in the first line as well as subsequent settings.
Unique toxicities presented with talquetamab tend to get progressively better as the treatment course continues, according to Prerna Mewawalla, MD.
Related Content